Boston Scientific (BSX) Cash from Operations (2009 - 2026)

Boston Scientific (BSX) has 18 years of Cash from Operations data on file, last reported at 348000000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 35.67% year-over-year to 348000000.0; the trailing twelve-month figure through Mar 2026 stood at 4341000000.0 (up 13.88% YoY), and the FY2025 full-year result was 4534000000.0, up 31.99% from the prior year.
• Cash from Operations retreated to 348000000.0 in Q1 2026, from 1364000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1456000000.0 in Q4 2024 to a low of 58000000.0 in Q1 2022.
• A 5-year average of 726235294.12 and a median of 698000000.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations plunged 120.42% in 2022 and jumped 427.59% in 2023, its largest moves.
• Tracing BSX's Cash from Operations over 5 years: stood at 807000000.0 in 2022, then gained by 18.59% to 957000000.0 in 2023, then soared by 52.14% to 1456000000.0 in 2024, then declined by 6.32% to 1364000000.0 in 2025, then tumbled by 74.49% to 348000000.0 in 2026.
• Business Quant data shows BSX's Cash from Operations at 348000000.0 in Q1 2026, 1364000000.0 in Q4 2025, and 1343000000.0 in Q3 2025.